Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zimmer clearly up on its knees

This article was originally published in Clinica

Executive Summary

Zimmer's knee franchise posted strong growth in the fourth quarter, helping the orthopaedics market leader to turn in a strong set of results. Up 21% at $327m, knee sales grew faster than the market, which Morgan Stanley estimates to have expanded by about 19-20% in the quarter. Total group sales were up 14% at $801m, and the particularly strong contribution from the high-margin knee products fed into a 2.3 percentage point increase in gross margins to 76.4%. Net earnings rose from $37m to $200m.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054212

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel